Novo Nordisk offers diabetes drug Ozempic for less than half the price for cash-paying U.S. patients August 18, 2025 John Cooper Global Market No comments yet **Novo Nordisk’s Ozempic Pricing Strategy: A Game-Changer for Investors?** **market Context: A Shift in Healthcare Affordability** The healthcare in… Read more
Novo Falls by Record as Wegovy Slumps and Insider Named CEO July 29, 2025 John Cooper Global Market No comments yet **Novo Nordisk Shakes Up Leadership Amidst Slumping Weight-Loss Drug Sales** **New CEO Takes the Helm Amidst Market Turmoil** In a move aimed at revitalizing the company’s fortunes, Novo Nordisk A/S… Read more